Table 2.
SSRI Exposed n=15,729 | Psychiatric Disorder, no medication exposed n=9,651 | SSRI Discontinued Group n=7,980 | Unexposed n=31,394 | |||||
---|---|---|---|---|---|---|---|---|
Offspring diagnosis | n | Cumulative incidence,a % (95% CI) | n | Cumulative incidence,a % (95% CI) | n | Cumulative incidence,a % (95% CI) | n | Cumulative incidence,a % (95% CI) |
Depression | 60 | 8.2 (3.1-13.3) | 30 | 1.9 (0.9-2.9) | 25 | 2.8 (1.4-4.3) | 30 | 1.6 (0.8-2.4) |
Anxiety | 65 | 3.1 (1.8-4.3) | 39 | 2.3 (1.3-3.2) | 27 | 2.6 (0.9-4.2) | 62 | 1.1 (0.6-1.6) |
ASD | 88 | 2.7 (1.9-3.5) | 79 | 2.3 (1.9-2.8) | 40 | 1.3 (0.8-1.8) | 100 | 1.1 (0.8-1.4) |
ADHD | 160 | 4.9 (3.8-6.0) | 137 | 4.2 (3.5-5.0) | 93 | 4.1 (3.1-5.1) | 124 | 1.7 (1.3-2.0) |
Note: Depression included depressive disorders and unspecified affective disorders (International Classification of Diseases 10th Revision [ICD-10] code: F32-39). ICD-10 code for anxiety: F40-41. ICD-10 code for ASD: F84 (excluding Rett's syndrome, F84.2). ADHD (ICD-10 F90).
Kaplan-Meier method.